Tuesday, January 3, 2017

BRIEF-VolitionRx Limited's novel cancer diagnostic test achieves CE marking

* Volitionrx ltd - achieved CE marking on its NU.Q

colorectal cancer screening triage test on Dec. 28, 2016, paving

way for its expected launch across EU

Source text for Eikon:

Further company...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)